Hap Trading, LLC Editas Medicine, Inc. Put Options Transaction History
Hap Trading, LLC
- $1.06 Trillion
- Q2 2025
Put Options
14 transactions
Others Institutions Holding EDIT
# of Institutions
217Shares Held
48MCall Options Held
637KPut Options Held
292K-
Black Rock Inc. New York, NY7.78MShares$19.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.97MShares$17.7 Million0.0% of portfolio
-
Nuveen, LLC Charlotte, NC2.09MShares$5.31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$5.18 Million0.0% of portfolio
-
State Street Corp Boston, MA1.93MShares$4.89 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $175M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...